• Text Size: Decrease Text SizeIncrease Text Size
  • Printer Friendly Version

Monarch Robotic Bronchoscopy

(228) 539-3356 or (228) 575-1775


Robotic Bronchoscopy Could Enable Earlier and More-Accurate Diagnosis of Lung Nodules

A new innovation that holds promise to fight lung cancer is now in use at Memorial. Used to view the inside of the lungs and obtain a tissue sample for biopsy, the goal of Auris Health’s Monarch™ Platform is to enable earlier and more-accurate diagnosis of small and hard-to-reach nodules in the periphery of the lung.

The technology integrates the latest advancements in robotics, software, data science, and endoscopy (the use of small cameras and tools to enter the body through its natural openings). Memorial is among the first hospitals in the United States to utilize the platform.

More than 90 percent of people diagnosed with lung cancer do not survive the disease, in part because it is often found at an advanced stage. There are a variety of diagnostic options currently available for lung cancer, but all have limitations in accuracy, safety, or invasiveness. These limitations can lead to false positives, false negatives, or side effects such as pneumothorax (collapsed lung) and hemorrhage, which may increase health care costs and extend hospital stays.

The Monarch Platform utilizes a familiar controller-like interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with improved reach, vision, and control. Combining traditional endoscopic views into the lung with computer-assisted navigation based on 3-D models of the patient’s own lung anatomy, the Monarch Platform provides physicians with continuous bronchoscope vision throughout the entire procedure.

  • Joseph Bosarge, MD
  • Summer Allen, MD